Unique Device Identification

Slides:



Advertisements
Similar presentations
GS1 Standards in Healthcare Nicolas Stuyckens GS1 Belgium & Luxembourg.
Advertisements

1 Mr. Bing Yuan Liou, Senior Specialist, Bureau of Standards, Metrology and Inspection, Ministry of Economic Affairs BSMI web site:
Traceability in Healthcare II Vision June/July 2011.
Unique Device Identification (UDI) System for Medical Devices Dr Larry Kelly Therapeutic Goods Administration.
GMDN Global Medical Device Nomenclature
ISO/TS WHO Informal Consultation on Nomenclatures for Medical Devices March 23-24, 2011 Leighton Hansel Convener ISO/TC210 WG3 Symbols and Nomenclature.
WHO Good Distribution Practices for Pharmaceutical Products
1 Targeted Case Management (TCM) Changes Iowa Medicaid Enterprise October 14, 2008.
Electronic Submission of Medical Documentation (esMD) eDoC Administrative Documents Templates for HL7 Orders October 25, 2013.
Unique Device Identification and the EHR
Configuration management
Presentation of the proposed Annex 19 – Safety Management
Biopharmaceutical Quality
Regulatory Pathway for Platform Technologies
Unique Device Identification (UDI) and Health Information Standards
Comparison GHTF/SG5/N5:2012 vs. MEDDEV 2.7/3:2010
UDI: From Regulation to Value What Hospitals and Healthcare Systems Can and Should Do, Now Presented by Karen Conway, AHRMM Board and Executive Director,
Overview of FDA Device Regulations
Overview of Device Regulations David Arvelo Small Business Representative.
“The Honeywell Web-based Corrective Action Solution”
Primary and secondary use of EHR: Enhancing clinical research Pharmaceutical Industry Perspectives Dr. Karin Heidenreich Senior Public Affairs Manager/Novartis.
 Copyright 2008 by Axendia, Inc. 1 Prepared for Advamed 2008 What You Should Know About Launching Medical Devices in the North American Market By Daniel.
Unique Device Identifier (UDI) - Overview 6/21/2014
NHS eProcurement Strategy Trade Association Meeting 24 th November 2014DH – Leading the nation’s health and care.
Track and Trace PSSNY 2015 Mid-Winter Conference Al Emmans
ILISA B.G. BERNSTEIN, PHARM.D., J.D. U.S. Food and Drug Administration
510k Submission Overview Myraqa, Inc. August 22, 2012.
UDI and the GMDN (Global Medical Device Nomenclature)
FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.
Postmarket Surveillance for Medical Devices
GS1 Healthcare Roadmap January 2015.
Medical Devices Approval Process
The FDA Landscape AdvaMed September 2008 Judith K. Meritz
Unique Device Identification and Global Medical Device Nomenclature Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
1 Unique Device Identification (UDI) – Enabling the Transformation of Medical Device Safety Terrie Reed, MSIE Associate Director, Informatics
1 Nothing is more difficult to undertake, more perilous to conduct or more uncertain in its outcome, than to take the lead in introducing a new order of.
Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration
Unique Device Identification (UDI): Implementation and Adoption Leslie M Tompkins, PhD FDA, Center for Devices and Radiological Health UDI Lead, Standards.
DRAFT Guidance for Industry: Providing Regulatory Submissions in Electronic Format – Drug Establishment Registration and Drug Listing Denise Sánchez, J.D.,
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
UDI: From Regulation to Value
GS1 US INITIATIVES UPDATE MARCH 18, GS1 STANDARDS MAKES IT POSSIBLE 2 SAFETYSECURITY VISIBILITYEFFICIENCY COLLABORATION To apply standards to business.
March 28, 2006 Combination Products: Preparing for the Journey March 28, 2006 Pamela J. Weagraff Principal Consultant.
1 CONSENSUS STANDARDS OIVD WORKSHOP April 22-23, 2003 Rockville MD Ginette Y. Michaud, M.D. OIVD.
© Siemens AG 2014 Alle Rechte vorbehalten.siemens.com/lowvoltage New Legislative Framework (NLF) Sektor Infrastructure & Cities | Division Low and Medium.
FDLI Introduction to Medical Device Law and Regulation Other Postmarket Controls Philip Katz (202) October 29, 2002 Washington,
1 In attempting to arrive at the truth, I have applied everywhere for information, but in scarcely an instance have I been able to obtain hospital records.
Utah Life Science Summit Nov Phil Triolo, PhD RAC President, Phil Triolo and Associates LC.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
1 October, 2015 HL 7 Working Group Meeting. FDA UDI Rule – 9/24/2013 Unique device identifier (UDI) means an identifier that adequately identifies a device.
GS1 DataMatrix Instructions
When Supply Chain meets Care Delivery: Background on GS1 and HL7 Ulrike Kreysa Director Healthcare, GS1 Global Office.
Medical Device Regulations in Canada; Key Challenges and International Initiatives.
1 Summary of FDA Guidance for Industry Standards for Securing the Drug Supply Chain – Standardized Numerical Identification for Prescription Drug Packages.
THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS, MEDICAL DEVICES AND BIOCIDAL PRODUCTS Responsibility in the handling of medical devices.
NOTE: To change the image on this slide, select the picture and delete it. Then click the Pictures icon in the placeholder to insert your own image. National.
GS1 DataMatrix Instructions
Unique Device Identification Update – FDA and GHTF
Postmarket Assessment in the U.S. and Unique Device Identifiers (UDI)
FDA-CDRH in the Next Decade A Vision for Change
Proposal for a Regulation on medical devices and Proposal for a Regulation on in vitro diagnostic medical devices Key Provisions and GIRP Assessment.
HL7 International January Working Group Meeting Health Care Device WG
Combination products The paradigm shift
Linda M. Chatwin, Esq. RAC Business Manager, UL LLC
NEW MDR Regulatory Context. NEW MDR Regulatory Context.
FDA Sentinel Initiative
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Global Medical Device Nomenclature (GMDN)
Towards International Harmonized Nomenclature for Medical Devices
Presentation transcript:

Unique Device Identification Jay Crowley Senior Advisor for Patient Safety Food and Drug Administration jay.crowley@fda.hhs.gov 301-980-1936

Current Device Identification Non-standard device identification systems; standards used in different ways Not necessary unique or unambiguous Does not include all necessary levels of uniqueness Manufacturers’ own number/catalogue number Distributors’ – apply different, proprietary number; lot or serial number not captured Hospital – yet different identification number/code Information on use not usually captured Control numbers rarely captured

Future Device Identification Develop a system to identify medical devices, which is: Consistent Unambiguous (differentiates among all dimensions) Standardized Unique at all levels of packaging Harmonized internationally And facilitates the: Storage, Exchange, and Integration of data and systems

UDI brings… Global Visibility Medical device recalls Adverse event reporting and postmarket surveillance Tracking and tracing, supply chain security; and anti-counterfeiting/diversion (location systems) Comparative effectiveness (e.g., registries) Disaster/terror preparation and shortages/substitutions Reduce medical errors Documenting medical device use in patient’s EHR/PHR, hospital information systems, claims data Sentinel Initiative - strengthening FDA’s ability to query data systems for relevant device information

FDA Amendments Act of 2007 September 27, 2007, the FDAAA signed into law: The Secretary shall promulgate regulations establishing a unique device identification system for medical devices requiring the label of devices to bear a unique identifier, unless the Secretary requires an alternative placement or provides an exception for a particular device or type of device. The unique identifier shall adequately identify the device through distribution and use, and may include information on the lot or serial number.

GHTF UDI ADWG Formed October 2008 EC Chair (Laurent Selles) Members US (FDA, AdvaMed), Europe (EC, Eucomed, EDMA), Japan, Canada AHWP recently joined (China) Washington April 2010; Brussels June 2010; Ottawa September 2010 Guidance submitted to Nov 2010 SC meeting Public Document – available at: http://www.ghtf.org/ahwg/ahwg-proposed.html Comments due by 30 April 2011.

Establishing a UDI System Combination of 4 distinct steps: Develop a standardized system to develop the unique device identifiers (UDI) Place the UDI in human readable and/or AutoID on a device, its label, or both Create and maintain the UDI Database Adoption and Implementation

1st – Developing the UDI Develop UDI code according to ISO 15459 [GS1, HIBCC] Created and maintained by the manufacturer Concatenating Device and Production Identifier Device Identifier (DI): [static] Manufacturer, make, model [i.e., each catalogue number] Production Identifier (PI): [dynamic] however product is currently controlled – serial, lot number; expiration, manufacturing date

2nd – UDI Application • Unique UDI applied to all levels of packaging, down to the lowest level (patient use/ unit of use) • Human readable and/or encoded in a form of automatic identification technology No specific technology would be identified (technology neutral) Identify a series of standards (linear barcode, 2-dimensional barcode, RFID) Direct Part Marking (DPM) for some devices

UDI Application Example

UDI Application Example

UDI Application Example

Combination Products and Kits Like other devices – intended to facilitate identification: Combination product (device) has its own UDI; each device should have its own UDI. Each kit (devices only) has its own UDI; each device in a kit should also have its own UDI.

3rd – Global UDI Database Device Identifier Type/Code [GTIN, HIBCC] Make/model; Brand/Trade Name; Size; Description Device model number (or reference number) Unit of Measure/Packaging level/quantity Controlled by – Lot and/or Serial Number; Exp. Date Contact name, phone, email GMDN Classification code/term Storage condition; Single Use; Sterility Contains known, labeled allergen (e.g., latex) FDA premarket authorization (510k, PMA) FDA Listing Number

FDA’s UDI Database FDA FDA Managed Business Rules FDA’s UDI Database The label of Medical Device 123 Size 45: Device Identifier (Device XYZ123) Production Identifier (Lot #ABC) Expiration date (MMDDYYYY) Sterile; Latex free Manufacturer (Acme) Distribution FDA Minimum Data Set For each Device Identifier: Manufacturer and model GMDN Code Other attributes FDA Managed Business Rules FDA’s UDI Database HL7 SPL GSI GDSN or Web based tool or Public User Interface Bulk HL7 SPL

Implementation Based on premarket risk class: class III – 12 months after final rule class II – 36 months after final rule class I – 60 months after final rule Allows stakeholders to jointly learn and for mid-course corrections Phase out national numbering system (NDC/NHRIC) Robust alternate placement and exception process Expect manufacturers and groups of manufacturers to submit requests – results of which will posted.

4th – Adoption and Implementation • Facilitate distributor uptake and use Facilitate hospital uptake and use Facilitate use of UDI throughout device lifecycle Drive integration – MMIS-Clinical Drive appropriate use of UDI in EHRs – and use of EHRs for registries and other postmarket activities

UDI Database Pilots Phase 3 – Purpose: Assess the feasibility of collecting, storing, and retrieving UDI data from initial creation (manufacturer) to point of use (hospital) . Phase 4 – Purpose: Assess how UDI data will impact FDA device information use in current systems

Unique Device Identification www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance/ UniqueDeviceIdentifiers Email: cdrhudi@fda.hhs.gov